Hanan M. El-Nahas

817 total citations
45 papers, 653 citations indexed

About

Hanan M. El-Nahas is a scholar working on Pharmaceutical Science, Biomaterials and Epidemiology. According to data from OpenAlex, Hanan M. El-Nahas has authored 45 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pharmaceutical Science, 9 papers in Biomaterials and 7 papers in Epidemiology. Recurrent topics in Hanan M. El-Nahas's work include Advanced Drug Delivery Systems (21 papers), Drug Solubulity and Delivery Systems (18 papers) and Advancements in Transdermal Drug Delivery (9 papers). Hanan M. El-Nahas is often cited by papers focused on Advanced Drug Delivery Systems (21 papers), Drug Solubulity and Delivery Systems (18 papers) and Advancements in Transdermal Drug Delivery (9 papers). Hanan M. El-Nahas collaborates with scholars based in Egypt, Saudi Arabia and Japan. Hanan M. El-Nahas's co-authors include Tarek Ibrahim, Heba S. Elsewedy, Mahmoud A. Mahdy, Marwa H. Abdallah, Gehan F. Balata, Noura G. Eissa, Bandar E. Al‐Dhubiab, Tamer M. Shehata, Hany M. El‐Bassossy and Eman Gomaa and has published in prestigious journals such as Colloids and Surfaces A Physicochemical and Engineering Aspects, Current Pharmaceutical Design and European Journal of Pharmaceutical Sciences.

In The Last Decade

Hanan M. El-Nahas

42 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanan M. El-Nahas Egypt 17 372 131 117 83 54 45 653
Ahmed R. Gardouh Egypt 13 390 1.0× 134 1.0× 171 1.5× 88 1.1× 62 1.1× 41 703
Boontida Morakul Thailand 10 354 1.0× 131 1.0× 103 0.9× 58 0.7× 52 1.0× 15 561
Dinesh Jain India 11 394 1.1× 120 0.9× 140 1.2× 69 0.8× 55 1.0× 39 720
Shefaat Ullah Shah Pakistan 18 397 1.1× 165 1.3× 113 1.0× 81 1.0× 58 1.1× 52 746
Sally A. El‐Zahaby Egypt 15 280 0.8× 100 0.8× 176 1.5× 70 0.8× 55 1.0× 34 687
Veintramuthu Sankar India 14 373 1.0× 125 1.0× 134 1.1× 92 1.1× 58 1.1× 49 699
Renuka S. Managuli India 14 330 0.9× 144 1.1× 167 1.4× 80 1.0× 72 1.3× 18 726
Mahendra Singh India 16 208 0.6× 105 0.8× 163 1.4× 100 1.2× 50 0.9× 38 749
Panchaxari M. Dandagi India 19 579 1.6× 157 1.2× 141 1.2× 87 1.0× 67 1.2× 78 878
Srinivas Reddy Jitta India 12 287 0.8× 110 0.8× 194 1.7× 77 0.9× 39 0.7× 17 578

Countries citing papers authored by Hanan M. El-Nahas

Since Specialization
Citations

This map shows the geographic impact of Hanan M. El-Nahas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanan M. El-Nahas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanan M. El-Nahas more than expected).

Fields of papers citing papers by Hanan M. El-Nahas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanan M. El-Nahas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanan M. El-Nahas. The network helps show where Hanan M. El-Nahas may publish in the future.

Co-authorship network of co-authors of Hanan M. El-Nahas

This figure shows the co-authorship network connecting the top 25 collaborators of Hanan M. El-Nahas. A scholar is included among the top collaborators of Hanan M. El-Nahas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanan M. El-Nahas. Hanan M. El-Nahas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Eissa, Noura G., et al.. (2024). Polymeric linagliptin nanoparticles as a sustained release treatment for type 2 diabetes. Journal of Drug Delivery Science and Technology. 93. 105438–105438. 6 indexed citations
4.
El-Nahas, Hanan M., et al.. (2024). Sustained linagliptin administration: superior glycemic control and less pancreatic injury in diabetic rats. Pharmaceutical Development and Technology. 29(8). 874–885.
5.
Alyami, Mohammad H., et al.. (2023). Oral bioavailability enhancement of doxazosin mesylate: Nanosuspension versus self-nanoemulsifying drug delivery systems. ADMET & DMPK. 12(1). 167–176. 1 indexed citations
6.
Abdallah, Marwa H., Amr S. Abu Lila, Hanan M. El-Nahas, & Tarek Ibrahim. (2023). Optimization of Potential Nanoemulgels for Boosting Transdermal Glimepiride Delivery and Upgrading Its Anti-Diabetic Activity. Gels. 9(6). 494–494. 9 indexed citations
7.
Gomaa, Eman, et al.. (2023). Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control. Saudi Pharmaceutical Journal. 31(4). 499–509. 14 indexed citations
8.
Youssef, Doaa Mohammed, et al.. (2023). Evaluation of ceftriaxone pharmacokinetics in hospitalized Egyptian pediatric patients. European Journal of Pediatrics. 182(10). 4407–4420. 3 indexed citations
9.
Mahdy, Mahmoud A., et al.. (2023). Design of mirtazapine solid dispersion with different carriers’ systems: optimization, in vitro evaluation, and bioavailability assessment. Drug Delivery and Translational Research. 13(9). 2340–2352. 11 indexed citations
11.
Shehata, Tamer M., Hanan M. El-Nahas, & Heba S. Elsewedy. (2022). Development, Characterization and Optimization of the Anti-Inflammatory Influence of Meloxicam Loaded into a Eucalyptus Oil-Based Nanoemulgel. Gels. 8(5). 262–262. 26 indexed citations
12.
El-Nahas, Hanan M., et al.. (2022). Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion. Saudi Pharmaceutical Journal. 30(11). 1589–1602. 17 indexed citations
13.
Ibrahim, Tarek, et al.. (2021). An overview of PLGA in-situ forming implants based on solvent exchange technique: effect of formulation components and characterization. Pharmaceutical Development and Technology. 26(7). 709–728. 36 indexed citations
14.
Elsewedy, Heba S., Bandar E. Al‐Dhubiab, Mahmoud A. Mahdy, & Hanan M. El-Nahas. (2021). Basic Concepts of Nanoemulsion and its Potential application in Pharmaceutical, Cosmeceutical and Nutraceutical fields. Research Journal of Pharmacy and Technology. 3938–3946. 15 indexed citations
15.
Elsewedy, Heba S., et al.. (2021). A Review Article on the Basic Concepts of Drug Delivery Systems as Targeting Agents. 10(1). 23–29. 11 indexed citations
16.
Ibrahim, Tarek, et al.. (2018). Transdermal ethosomal gel nanocarriers; a promising strategy for enhancement of anti-hypertensive effect of carvedilol. Journal of Liposome Research. 29(3). 215–228. 51 indexed citations
17.
El-Nahas, Hanan M., et al.. (2018). Injectable PLGA Adefovir microspheres; the way for long term therapy of chronic hepatitis-B. European Journal of Pharmaceutical Sciences. 118. 24–31. 21 indexed citations
18.
Lila, Amr S. Abu, et al.. (2015). Encapsulation in a rapid-release liposomal formulation enhances the anti-tumor efficacy of pemetrexed in a murine solid mesothelioma-xenograft model. European Journal of Pharmaceutical Sciences. 81. 60–66. 16 indexed citations
19.
Balata, Gehan F., et al.. (2013). Propolis organogel as a novel topical delivery system for treating wounds. Drug Delivery. 21(1). 55–61. 36 indexed citations
20.
El-Nahas, Hanan M., et al.. (2006). FORMULATION AND EVALUATION OF MELOXICAM GELS FOR TOPICAL ADMINISTRATION. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026